139 related articles for article (PubMed ID: 28286116)
1. Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels.
Zhang M; Chang W; Shi H; Zhou Y; Zheng S; Li Y; Li L; Lou H
Toxicol Appl Pharmacol; 2017 May; 322():104-112. PubMed ID: 28286116
[TBL] [Abstract][Full Text] [Related]
2. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production.
Chang W; Li Y; Zhang L; Cheng A; Lou H
PLoS One; 2012; 7(7):e41624. PubMed ID: 22848547
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of a maleimide compound on the virulence factors of
Li Y; Chen C; Cong L; Mao S; Shan M; Han Z; Mao J; Xie Z; Zhu Z
Virulence; 2023 Dec; 14(1):2230009. PubMed ID: 37367101
[TBL] [Abstract][Full Text] [Related]
4. Natural product solasodine-3-O-β-D-glucopyranoside inhibits the virulence factors of Candida albicans.
Li Y; Chang W; Zhang M; Ying Z; Lou H
FEMS Yeast Res; 2015 Sep; 15(6):. PubMed ID: 26162798
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus mutans sigX-inducing peptide inhibits the virulence of Candida albicans and oral candidiasis through the Ras1-cAMP-Efg1 pathway.
Zhang K; Sun IG; Liao B; Yang Y; Ma H; Jiang A; Chen S; Guo Q; Ren B
Int J Antimicrob Agents; 2023 Aug; 62(2):106855. PubMed ID: 37211262
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of trans-cinnamaldehyde on the virulence of Candida albicans via enhancing farnesol secretion with low potential for the development of resistance.
Ying L; Mingzhu S; Mingju Y; Ye X; Yuechen W; Ying C; Bing G; Hongchun L; Zuobin Z
Biochem Biophys Res Commun; 2019 Aug; 515(4):544-550. PubMed ID: 31176484
[TBL] [Abstract][Full Text] [Related]
7. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.
Davis-Hanna A; Piispanen AE; Stateva LI; Hogan DA
Mol Microbiol; 2008 Jan; 67(1):47-62. PubMed ID: 18078440
[TBL] [Abstract][Full Text] [Related]
8. Sho1p Connects Glycolysis to Ras1-cAMP Signaling and Is Required for Microcolony Formation in Candida albicans.
Kumar R; Maulik M; Pathirana RU; Cullen PJ; Edgerton M
mSphere; 2020 Jul; 5(4):. PubMed ID: 32641426
[No Abstract] [Full Text] [Related]
9. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
10.
Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
[TBL] [Abstract][Full Text] [Related]
11. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
[TBL] [Abstract][Full Text] [Related]
12. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans.
Hans S; Fatima Z; Hameed S
J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Yeast-to-Hypha Transition and Virulence of
Meng L; Zhao H; Zhao S; Sun X; Zhang M; Deng Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670437
[TBL] [Abstract][Full Text] [Related]
14. A functional link between hyphal maintenance and quorum sensing in Candida albicans.
Polke M; Sprenger M; Scherlach K; Albán-Proaño MC; Martin R; Hertweck C; Hube B; Jacobsen ID
Mol Microbiol; 2017 Feb; 103(4):595-617. PubMed ID: 27623739
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Compounds Isolated from
Meng L; Sun C; Zhang C; Song S; Sun X; Ju J; Deng Y
Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31357504
[No Abstract] [Full Text] [Related]
16. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
Chen S; Xia J; Li C; Zuo L; Wei X
BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11.
Morici P; Fais R; Rizzato C; Tavanti A; Lupetti A
PLoS One; 2016; 11(11):e0167470. PubMed ID: 27902776
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
Tashiro M; Kimura S; Tateda K; Saga T; Ohno A; Ishii Y; Izumikawa K; Tashiro T; Kohno S; Yamaguchi K
Med Mycol; 2012 May; 50(4):353-60. PubMed ID: 21954955
[TBL] [Abstract][Full Text] [Related]
19. The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.
Jadhav A; Bansode B; Phule D; Shelar A; Patil R; Gade W; Kharat K; Karuppayil SM
World J Microbiol Biotechnol; 2017 May; 33(5):96. PubMed ID: 28409362
[TBL] [Abstract][Full Text] [Related]
20. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.
Zhang L; Chang W; Sun B; Groh M; Speicher A; Lou H
PLoS One; 2011; 6(12):e28953. PubMed ID: 22174935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
